Aciclovir-induced neurotoxicity

Pract Neurol. 2023 Apr;23(2):157-159. doi: 10.1136/pn-2022-003597. Epub 2022 Dec 8.

Abstract

Aciclovir-induced neurotoxicity results from the accumulation of aciclovir and its metabolite 9-carboxymethoxymethylguanine (CMMG). It occurs predominantly in older patients with impaired renal function and is characterised by a combination of confusion and psychiatric changes. Seizures, myoclonus and dysarthria may also occur. Critically, peritoneal dialysis has little effect on reversing the toxic effects of aciclovir. We describe a woman in her 70s with renal failure who developed confusion and seizures after receiving aciclovir. She was ultimately diagnosed with aciclovir-induced neurotoxicity, confirmed by an elevated serum CMMG concentration. This condition is likely to be underdiagnosed and the neurologist's primary challenge is differentiating aciclovir-induced neurotoxicity from viral encephalitis.

Keywords: NEUROTOXICOLOGY; PHARMACOLOGY.

MeSH terms

  • Acyclovir / adverse effects
  • Aged
  • Antiviral Agents / adverse effects
  • Confusion
  • Encephalitis, Viral*
  • Female
  • Humans
  • Neurotoxicity Syndromes* / etiology
  • Neurotoxicity Syndromes* / therapy
  • Seizures / drug therapy

Substances

  • Acyclovir
  • Antiviral Agents